Upcoming Events

CMS DMEPOS/Home Health Final Rule: What It Means for HME Providers and How We’re Fighting Back

The Centers for Medicare & Medicaid Services (CMS) has issued the DMEPOS Home Health Final Rule, restarting competitive bidding for new product categories: Class II CGMs & Insulin Pumps, Urological Supplies, Ostomy Supplies, and Hydrophilic Urinary Catheters; these will be furnished via Remote Item Delivery. CMS recently confirmed that legacy products from previous CB rounds will not be in this next round. Even with these legacy products removed, provisions in the rule will have significant impacts on the DME community, vulnerable patients and caregivers, and the broader healthcare continuum.

AAHomecare invites you to a webinar that will equip you with the facts, timelines, and strategies you need to protect your business and patients — and to join our fight for fair, sustainable policies.

This webinar will break down:

- The facts behind the Final Rule — what’s included, what’s changing, and what it means for your business.
- Intel received from the Administration — a transparent look at the regulatory process.
- Timeline for the Final Rule — when changes take effect and what deadlines you need to know.
- Provider Enrollment requirements — how enrollment processes are evolving and what providers must do to stay compliant.
- Accreditation process — updates on plan to move accreditation to an annual process and the impact on provider operations.
- Our strategy moving forward — how the Association is working to delay the next bidding round or improve its framework on behalf of diabetes, ostomy, and urological product stakeholders who will be subject to bidding and address other issues that remain in the Final Rule.

This is more than an update — it’s your chance to understand the stakes, prepare your organization, and stand with the industry in shaping the future of home medical equipment.